Novo Nordisk sets the list price for Wegovy at over $1,300/month, reflecting their investment in clinical trials, manufacturing, and regulatory approval
Future studies, like the SURPASS-CVOT study (NCT04255433), will assess the cardiovascular (CV) safety and efficacy of tirzepatide against dulaglutide (1.5 mg) in people with established coronary heart disease (ASCVD) and type 2 diabetes
Both semaglutide and tirzepatide labels include warnings that patients should understand before treatment
Additionally, participants consumed approximately 23 times the recommended daily intake over a period of 10 years
Best peptides for back pain ranked by effectiveness Based on mechanism of action, available research, and practical experience from the peptide community, these peptides offer the most promise for back pain conditions
How does Semaglutide for type 2 diabetes impact UTI risk